BlueLinx Holdings Inc. — Form 10-Q summary
Reporting period: Quarter ended October 4, 2014; nine months ended October 4, 2014. The request metadata says 2013 Q3, but the filing itself reports fiscal 2014 Q3.
Business context
BlueLinx distributes structural and specialty building products through 49 distribution centers. Structural products represented about 42% of Q3 gross sales; specialty products about 58% of net sales. The business is seasonal, with Q2 and Q3 typically strongest, and remains sensitive to housing activity, weather, product prices, and construction demand.
Financial performance
| Metric | Q3 2014 | Q3 2013 | First 9 months 2014 | First 9 months 2013 |
|---|---|---|---|---|
| Net sales | $549.8 million | $558.0 million | $1,525.3 million | $1,665.7 million |
| Gross profit / margin | $64.6 million / 11.7% | $62.5 million / 11.2% | $179.3 million / 11.8% | $174.1 million / 10.5% |
| Operating income (loss) | $6.0 million | $3.1 million | $14.1 million | $(17.6) million |
| Net income (loss) | $(0.9) million | $(3.2) million | $(6.2) million | $(38.2) million |
| Net loss per share | $(0.01) | $(0.04) | $(0.07) | $(0.49) |
Q3 sales declined 1.5%; same-center sales rose $14.3 million, offset by $22.4 million of lower sales associated with five centers closed in the 2013 restructuring. Q3 structural sales fell 4.5%, while specialty sales rose 1.1%; same-center specialty sales increased 6.1%. Gross profit increased as improved margin rates and a higher specialty-product mix offset lower volume. SG&A declined year over year, including lower payroll, commissions, freight, and fuel costs.
For the first nine months, sales fell 8.4%, primarily reflecting the closed centers and unusually harsh first-quarter weather. Operating results improved substantially as gross margin rates rose and SG&A fell 14.7%. Nine-month gross profit included a $1.4 million recovery of countervailing and antidumping duties. Prior-year gross margin was affected by a $4.8 million inventory-related reserve.
Cash flow, debt, and liquidity
- Operating cash flow was negative $53.4 million for the first nine months, versus negative $70.8 million in the prior-year period. Working-capital use included $55.5 million from receivables and $41.3 million from inventory, partly offset by a $45.0 million increase in accounts payable.
- Investing cash flow provided $5.4 million, including $7.2 million of asset-sale proceeds; capital expenditures were $1.8 million. Financing cash flow provided $50.8 million, mainly from net revolving-credit borrowings. Cash ended at $7.8 million.
- At October 4, current assets were $503.7 million and current liabilities $218.0 million. Balance-sheet debt was $454.2 million, including $71.7 million classified as current; stockholders’ deficit was $10.7 million.
- U.S. revolving-credit borrowings were $273.6 million, with $86.1 million excess availability; Canadian borrowings were $4.1 million, with $1.8 million availability. The company reported compliance with facility covenants. The U.S. facility matures April 2016; a $20 million Tranche A Loan was extended to June 30, 2015, with monthly availability reductions scheduled to begin in April 2015, subject to stated conditions.
- The $178.1 million mortgage, secured by 49 distribution facilities, matures July 2016; $175.0 million of principal is scheduled for 2016. Its stated fixed interest rate is 6.35%.
Outlook, risks, and unusual items
Management said it expected cash from operations and revolving-credit borrowings to fund routine operations and working-capital needs for at least the next 12 months. It also said that improving sales could require more inventory and receivables, reducing revolver availability, and that additional working capital would strengthen liquidity. The company viewed the housing recovery as progressing, with long-term demand expected to improve, but provided no numerical earnings or sales guidance.
Key risks cited include housing starts, construction demand, product-price and supply changes, customer creditworthiness, vendor supply, competition, fuel costs, weather, interest rates and access to capital, accidents and product-liability exposure, and cyber intrusion. The company reported no material change in risk factors and no material expected adverse effect from routine legal proceedings. No impairment losses were recorded in the first nine months.
Unusual items included $5.1 million of gain on the Portland facility sale and about $0.2 million related to the Fremont location, both recorded in SG&A during the first half of fiscal 2014. The effective tax rate reflected a full valuation allowance on year-to-date federal and state tax benefits, along with certain state, Canadian, and gross-receipts taxes.
Important facts for investors to verify
- Confirm the intended period: the filing is for Q3 2014, not Q3 2013 as indicated in the request metadata.
- Monitor working-capital needs, operating cash use, and remaining borrowing availability as seasonal demand changes.
- Review the 2015 Tranche A Loan availability step-down and the 2016 revolving-facility and mortgage maturities.
- Assess whether margin gains, lower costs, and specialty-product growth can persist despite weaker structural volumes and lower year-to-date sales.
- Check the effect of tax valuation allowances and facility-sale gains on reported results; the filing provides no quantified forward earnings guidance.